Evidence map›Paper›PMID 29383131›Full record

ArticleOncotarget2017

Development of a reliable and accurate algorithm to quantify the tumor immune stroma (QTiS) across tumor types.

Rainer Christoph Miksch, Jingcheng Hao, Markus Bo Schoenberg, Katharina Dötzer, Friederike Schlüter, Maximilian Weniger, Shuai Yin, Steffen Ormanns, Jan Goesta D'Haese, Markus Otto Guba and 3 more

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Apparent Lack ofFrontiers in immunology · 2019
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rainer Christoph Miksch *Department of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Jingcheng Hao *Department of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Markus Bo Schoenberg *Department of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Katharina DötzerDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Friederike SchlüterDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Maximilian WenigerDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Shuai YinDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Steffen OrmannsDepartment of Pathology, Ludwig-Maximilians University, Munich, Germany.
Jan Goesta D'HaeseDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Markus Otto GubaDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Jens WernerDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Barbara MayerDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.
Alexandr V BazhinDepartment of General, Visceral and Transplantation Surgery, Ludwig-Maximilians University, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment plays an important role in the tumor biology. Overall survival of tumor patients after resection is influenced by tumor-infiltrating lymphocytes (TILs) as a component of the tumor stroma. However, it is not clear how to assess TILs in the tumor stroma due to heterogeneous methods in different cancer types. Therefore, we present a novel Quantification of the Tumor immune Stroma (QTiS) Algorithm to reliably and accurately quantify cells in the tumor stroma. Immunohistochemical staining of CD3 and CD8 cells in sections of metastatic colorectal cancer (mCRC), ovarian cancer (OvCa), hepatocellular carcinoma (HCC), and pancreatic ductal adenocarcinoma (PDAC), alltogether

Indexed as

colorectal cancerhepatocellular carcinomaovarian cancerpancreatic cancertumor-infiltrating lymphocytes

Identifiers

PMID29383131
PMCPMC5777743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.